Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2016
A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer PatientsValentina Aristarco, Davide Serrano, Sara Gandini, et al.
The Pharmacogenomics Journal|April 11, 2019
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancerHarriet Johansson, Valentina Aristarco, Sara Gandini, et al.
Cancers|April 13, 2024
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up StudyMassimiliano Ruscica, Chiara Macchi, Sara Gandini, et al.
Biomedicines|June 28, 2023
Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized TrialDavide Serrano, Federica Bellerba, Harriet Johansson, et al.
Breast Cancer Research and Treatment|January 26, 2024
Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trialsHarriet Johansson, Federica Bellerba, Debora Macis, et al.
Cancers|October 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) StudySilvia Polidoro, Harriet Johansson, Giovanni Cugliari, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 13, 2017
A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast CancerMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 4, 2015
A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast CancerMatteo Lazzeroni, Aliana Guerrieri-Gonzaga, Sara Gandini, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker TrialValentina Aristarco, Davide Serrano, Patrick Maisonneuve, et al.
JNCI Cancer Spectrum|January 7, 2021
Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II TrialBernardo Bonanni, Davide Serrano, Patrick Maisonneuve, et al.
Pageof 4